The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease
Open accessAbstract
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) damages the nigrostriatal dopaminergic pathway as seen in Parkinson's disease (PD), a common neurodegenerative disorder with no effective protective treatment. Consistent with a role of glial cells in PD neurodegeneration, here we show that minocycline, an approved tetracycline derivative that inhibits microglial activation independently of its antimicrobial properties, mitigates both the demise of nigrostriatal dopaminergic neurons and the formation of nitrotyrosine produced by MPTP. In addition, we show that minocycline not only prevents MPTP-induced activation of microglia but also the formation of mature interleukin-1beta and the activation of NADPH-oxidase and inducible nitric oxide synthase (iNOS), three key microglial-derived cytotoxic mediators. Previously, we demonstrated that ablation of iNOS attenuates MPTP-induced neurotoxicity. Now, we demonstrate that iNOS is not the only microglial-related culprit implicated in MPTP-induced toxicity because mutant iNOS-deficient mice treated with minocycline are more resistant to this neurotoxin than iNOS-deficient mice not treated with minocycline. This study demonstrates that microglial-related inflammatory events play a significant role in the MPTP neurotoxic process and suggests that minocycline may be a valuable neuroprotective agent for the treatment of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect is mainly ascribable to the minocycline-dependent suppression of microglia activation, which has been reported by several in vivo studies [251,258,259,260,261,262,263].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
In the citing paper
“In this respect, microglial inactivation by minocycline correlates with decreased IL-1β formation, as well as reduced NADPH-oxidase and inducible nitric oxide synthase (iNOS) activity, suggesting that both anti-inflammatory and antioxidant pathways are involved [262,264].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
In the citing paper
“In this respect, microglial inactivation by minocycline correlates with decreased IL-1β formation, as well as reduced NADPH-oxidase and inducible nitric oxide synthase (iNOS) activity, suggesting that both anti-inflammatory and antioxidant pathways are involved [262,264].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
In the citing paper
“In this respect, microglial inactivation by minocycline correlates with decreased IL-1β formation, as well as reduced NADPH-oxidase and inducible nitric oxide synthase (iNOS) activity, suggesting that both anti-inflammatory and antioxidant pathways are involved [262,264].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [262]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Free Radicals in Biology and Medicine
Land, E. J. (1990) · International Journal of Radiation Biology · doi:10.1080/09553009014552071 · Cited by 4,871
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Microglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,111
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,060
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 19×
“…decreases MPTP-mediated nitrotyrosine formation A significant part of the MPTP neurotoxic process is mediated by NO-related oxidative damage (Przedborski et al., 2000), the extent of which can be evaluated by assessing nitrotyrosine levels (Liberatore et al., 1999; Pennathur et al., 1999).”
BackgroundMethodResultInfluentialYrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040
Banati, R. B., Gehrmann, J., Schubert, P., & Kreutzberg, G. W. (1993) · Glia · doi:10.1002/glia.440070117 · Cited by 1,032
Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia
Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Research works printed but not linked: 1
- Fahn S, Przedborski S (2000) Parkinsonism. In: Merritt's neurology (Rowland LP, ed), pp 679 -693. New York: Lippincott Williams & Wilkins.
Cited by
Sorted by citations
Items 901–999 of 999
Yokoyama, H., Yano, R., Kuroiwa, H., Tsukada, T., Uchida, H., Kato, H., Kasahara, J., & Araki, T. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9212-z · Cited by 17
Prothrombin Kringle-2: a potential inflammatory pathogen in the parkinsonian dopaminergic system
Leem, E., Jeong, K. H., Won, S.-Y., Shin, W.-H., & Kim, S. R. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.4.147 · Cited by 16
Huang, C., Li, R., Zeng, Q., Ding, Y., Zou, Y., Mao, X., Hu, W., Xiong, R., & Li, M. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-0090-y · Cited by 16
Tang, C.-M., Hwang, C., Chen, S., & Yang, D. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.024 · Cited by 16
Vasoactive intestinal peptide family as a therapeutic target for Parkinson’s disease
González‐Rey, E., Chorny, A., Fernandez‐Martin, A., Varela, N., & Delgado, M. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.5.923 · Cited by 16
Minocycline attenuates interferon-α-induced impairments in rat fear extinction
Bi, Q., Shi, L., Yang, P., Wang, J., & Qin, L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0638-z · Cited by 18
Signaling Mechanisms Underlying Toxicant-Induced Gliosis
O'Callaghan, J. P., & Sriram, K. (2004) · CRC Press eBooks · doi:10.1201/9781420039740.ch9 · Cited by 17
Ixodid Tick Species Infesting Cows and Buffaloes and Their Seasonality in West Azerbaijan
Adabi, S. G., Davoudi, J., & Rad, N. H. (2008) · Research Journal of Parasitology · doi:10.3923/jp.2008.98.103 · Cited by 15
Choi, J., Polcher, A. A., & Joas, A. (2016) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2016.en-955 · Cited by 18
Parkinson’s Disease: Is there a Role for Dietary and Herbal Supplements?
Onaolapo, O. J., Odeniyi, A. O., & Onaolapo, A. Y. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210218082954 · Cited by 15
Shen, S., Zhang, C., Xu, Y.-M., & Shi, C.-H. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212929 · Cited by 16
Pathology of Neurodegenerative Diseases
Kim, Y. S., Kim, Y.-K., Hwang, O., & Dong, J. (2012) · InTech eBooks · doi:10.5772/38028 · Cited by 16
Vautier, S., Milane, A., Fernandez, C., Chacun, H., Lacomblez, L., & Farinotti, R. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3b596 · Cited by 15
Ho, E. L., Spudich, S., Lee, E., Fuchs, D., Sinclair, E., & Price, R. W. (2011) · AIDS Research and Therapy · doi:10.1186/1742-6405-8-17 · Cited by 15
Stanić, D., Tripanichkul, W., Drago, J., Finkelstein, D. I., & Horne, M. K. (2004) · Brain Research · doi:10.1016/j.brainres.2004.07.012 · Cited by 15
Carmen, J., Gowing, G., Julien, J., & Kerr, D. A. (2006) · Glia · doi:10.1002/glia.20359 · Cited by 15
Pathogenic role of glial cells in Parkinson's disease
Przedborski, S., & Goldman, J. E. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31043-4 · Cited by 15
Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach
Kumar, A., Ghosh, D., & Singh, R. L. (2013) · Journal of Biomarkers · doi:10.1155/2013/538765 · Cited by 15
Lee, S. Y., Kim, B.-K., Jeong, H., Min, K., Liu, T., Park, J., Joe, E.-H., & Jou, I. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.07.008 · Cited by 14
Son, H. J., Han, S. H., Lee, J. A., Lee, C.-S., Seo, J. W., Yoon, D., & Hwang, O. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.009 · Cited by 14
Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's disease
Liang, L., Huang, J., Fulton, R. E., Pearson-Smith, J. N., Day, B. J., & Patel, M. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.04.004 · Cited by 14
Shen, Y., Guo, X., Han, C., Wan, F. J., Ma, K., Guo, S., Wang, L., Xia, Y. F., Liu, L., Lin, Z., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2549-2 · Cited by 15
Serra, M., Pinna, A., Costa, G., Usiello, A., Pasqualetti, M., Avallone, L., Morelli, M., & Napolitano, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105326 · Cited by 15
Future neuroprotective strategies
Sättler, M. B., & Bähr, M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.016 · Cited by 14
He, X., Feng, L., Meng, H., Wang, X., & Liu, S. (2012) · International Journal of Neuroscience · doi:10.3109/00207454.2012.686544 · Cited by 16
Rheumatoid Arthritis Accompanied by Parkinson Disease
Kogure, T., Tatsumi, T., Kaneko, Y., & Okamoto, K. (2008) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318178825f · Cited by 13
Noelker, C., Stuckenholz, V., Reese, J., Alvarez‐Fischer, D., Sankowski, R., Rausch, T. K., Oertel, W. H., Hartmann, A., van Patten, S., Al‐Abed, Y., et al. (2012) · Neurodegenerative Diseases · doi:10.1159/000342714 · Cited by 13
Yu, A. C., Neil‐Sztramko, S., & Quandt, J. A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.03.018 · Cited by 13
Saito, M., Sejima, H., Naito, T., Ushirogawa, H., Matsuzaki, T., Matsuura, E., Tanaka, Y., Nakamura, T., & Takashima, H. (2017) · Virology Journal · doi:10.1186/s12985-017-0902-6 · Cited by 13
Gonçalves, A. M. R., Pereira-Santos, A. R., Esteves, A. R., Cardoso, S. M., & Empadinhas, N. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7997 · Cited by 13
Gómez‐Nicola, D., & Perry, V. H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_18 · Cited by 13
Effects of Aspirin and Celecoxib on Rigidity in a Rat Model of Parkinson`s Disease
Moghaddam, H. F., Hemmati, A. A., Nazari, Z., Mehrab, H., ., K. M. A., & Ar, M. S. (2007) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2007.3853.3858 · Cited by 13
FimH adhesin of Escherichia coli K1 type 1 fimbriae activates BV-2 microglia
Lee, J., Shin, S., Teng, C., Hong, S. J., & Kim, K. S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.180 · Cited by 13
Steensel, M. A. M. V. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.12.040 · Cited by 13
Mostafeezur, R. M., Zakir, H. M., Yamada, Y., Yamamura, K., Iwata, K., Sessle, B. J., & Kitagawa, J. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-27 · Cited by 13
Tonouchi, A., Nagai, J., Togashi, K., Goshima, Y., & Ohshima, T. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13617 · Cited by 12
Schneider, J. S., Singh, G., Williams, C. K., & Singh, V. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103729 · Cited by 11
Tomas‐Grau, R. H., González‐Lizárraga, F., Ploper, D., Ávila, C. L., Socías, S. B., Besnault, P., Tourville, A., Mella, R. M., Villacé, P., Salado, C., et al. (2022) · Cells · doi:10.3390/cells11172759 · Cited by 12
Peng, S., Yu, Y., Li, J., Jiang, D., Xu, G., Wu, L., & Hu, J. (2023) · Aging · doi:10.18632/aging.204586 · Cited by 12
Ito, T., Suzuki, K., Uchida, K., & Nakayama, H. (2011) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2011.07.004 · Cited by 12
Jensen, S. K., & Yong, V. W. (2014) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12093 · Cited by 14
Liang, Y., Li, S., Zou, Q., & Su, B. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.061 · Cited by 12
Wright, A. K., Miller, C. E., Williams, M., & Arbuthnott, G. W. (2008) · Brain Research · doi:10.1016/j.brainres.2008.04.020 · Cited by 12
Pardo‐Peña, K., Lorea-Hernández, J. J., Camacho-Hernández, N. P., Ordaz, B., Villasana‐Salazar, B., Morales‐Villagrán, A., & Peña‐Ortega, F. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.032 · Cited by 13
Opposite Modulation of Peripheral Inflammation and Neuroinflammation by Adenosine A2A Receptors
Cunha, R. A., Chen, J., & Sitkovsky, M. V. (2007) · Springer eBooks · doi:10.1007/978-0-387-70830-0_3 · Cited by 12
Tetracycline Derivatives as Anti-inflammatory Agents and Potential Agents in Stroke Treatment
Koıstınaho, J., Yrjänheikki, J., Kauppinen, T. M., & Koistinaho, M. (2004) · Springer eBooks · doi:10.1007/978-3-662-05426-0_6 · Cited by 12
Chirico, F. D., Poeta, E., Babini, G., Piccolino, I., Monti, B., & Massenzio, F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1038721 · Cited by 11
Pawlak, C. R., Chen, F., Wu, F.-Y., & Ho, Y. (2012) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2012.02.010 · Cited by 11
Calabrese, E. J., Bhatia, T. N., Calabrese, V., Dhawan, G., Giordano, J., Hanekamp, Y. N., Kapoor, R., Kozumbo, W. J., & Leak, R. K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104371 · Cited by 12
Li, Z., Yang, X., Teng, P., Kong, D., Gao, S. H., Liu, Z., Yang, J., Gao, D., Luo, M., Wen, X., et al. (2021) · Instrumentation Science & Technology · doi:10.1080/10739149.2021.1912761 · Cited by 11
Yang, X., Ma, H., Yv, Q., Ye, F., Zhang, H., Chen, S., Keram, A., Li, W.-W., & Zhu, M. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.01.047 · Cited by 11
The Degenerating Substantia Nigra as a Susceptible Region for Gene Transfer-Mediated Inflammation
Roca, V., Casabona, J. C., Radice, P. D., Murta, V., & Pitossi, F. J. (2011) · Parkinson s Disease · doi:10.4061/2011/931572 · Cited by 12
Kaplan, B. L. F., Li, J., LaPres, J. J., Pruett, S. B., & Karmaus, P. W. F. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv060 · Cited by 11
Su, J., Wang, H., Yang, Y., Wang, J., Li, H., Huang, D., Huang, L., Bai, X., Yu, M., Fei, J., et al. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.06.010 · Cited by 11
Wang, X., Li, Y., Wang, Y., Feng, Q., Yang, P., & Qin, L. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.576994 · Cited by 11
Basic Science of PET Imaging for Inflammatory Diseases
Kubota, K., Ogawa, M., Ji, B., Watabe, T., Zhang, M., Suzuki, H., Sawada, M., Nishi, K., & Kudo, T. (2019) · Springer eBooks · doi:10.1007/978-981-15-0810-3_1 · Cited by 12
Alcohol Brain Damage and Neuroinflammation: Is There a Connection?
Syapin, P. J., Hickey, W. F., & Kane, C. J. M. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000167961.39176.e6 · Cited by 11
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Chou, V., Ko, N., Holman, T. R., & Manning-Bog, A. (2014) · Journal of Visualized Experiments · doi:10.3791/50960 · Cited by 11
Yılmaz, İ., Adıgüzel, E., Akdoğan, I., Kaya, E., & Hatip‐Al‐Khatib, I. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.02.027 · Cited by 11
Gazing into the future: Parkinson's disease gene therapeutics to modify natural history
Maguire‐Zeiss, K. A., Mhyre, T. R., & Federoff, H. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.09.030 · Cited by 11
Ma, T. C., Mihm, M. J., Bauer, J. A., & Hoyt, K. R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04735.x · Cited by 11
Minocycline treatment in acute stroke.
Goldstein, L. B. (2008) · PubMed · Cited by 11
Krishnan, M. (2023) · Bioinformation · doi:10.6026/97320630019729 · Cited by 12
Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson’s Disease
Serrano-Martínez, I., Pedreño, M., Castillo-González, J., Ferraz-de-Paula, V., Vargas-Rodríguez, P., Forte‐Lago, I., Caro, M., Campos‐Salinas, J., Villadiego, J., Peñalver, P., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020694 · Cited by 9
Sardoiwala, M. N., Biswal, L., & Choudhury, S. R. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c18226 · Cited by 10
Dunn, J. S., Nagi, S. S., & Mahns, D. A. (2020) · European Journal of Pain · doi:10.1002/ejp.1558 · Cited by 10
Labrador‐Garrido, A., Cejudo‐Guillén, M., Klippstein, R., Genst, E. D., Tomás‐Gallardo, L., Leal‐Lasarte, M., Villadiego, J., Toledo‐Aral, J. J., Dobson, C. M., Pozo, D., et al. (2014) · Immunity Inflammation and Disease · doi:10.1002/iid3.39 · Cited by 10
Jiamvoraphong, N., Jantaratnotai, N., Sanvarinda, P., Tuchinda, P., Piyachaturawat, P., Thampithak, A., & Sanvarinda, P. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12723 · Cited by 10
The association of Parkinson’s disease pathogenesis with inflammation
Saiki, S. (2014) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.54.1125 · Cited by 10
Induction of GAP‐43 modulates neuroplasticity in PBSC (CD34 + ) implanted‐Parkinson's model
Shyu, W., Li, K., Peng, H., Lin, S., Liu, R., Wang, H., Su, C., Lee, Y., & Li, H. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22027 · Cited by 10
Mounsey, R. B., Martin, H. L., Nelson, M. C., Evans, R. M., & Teismann, P. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.048 · Cited by 10
Przedborski, S., & Tieu, K. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.017 · Cited by 10
Huang, Y., Zhou, C., & Qu, S. (2025) · Communications Biology · doi:10.1038/s42003-025-08997-7 · Cited by 9
Melatonin, Oxidative Stress, and the Aging Brain
Bondy, S. B. C., & Sharman, E. H. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-602-3_17 · Cited by 9
SENP1 inhibits the IH-induced apoptosis and nitric oxide production in BV2 microglial cells
Liu, S., Wang, Z., Xu, B., Chen, K., Sun, J., & Ren, L. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.092 · Cited by 9
Liu, X., Chu, T., Su, H., Guo, A., & Wu, W. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1532-4 · Cited by 9
Tang, Y., & Le, W. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_4 · Cited by 10
Can we prevent parkinson's disease?
Christine, R. V. (2009) · Frontiers in bioscience · doi:10.2741/3331 · Cited by 9
Down-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss
Song, D., Yu, H.-N., Park, C.-R., Lee, J.-S., Lee, J., Park, B.-G., Woo, R., Han, J.-T., Cho, B., & Baik, T. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-112 · Cited by 8
Zhang, X., Shen, Z.-L., Ji, Y., Cui, Y., Xiao, C., & Zhou, C. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.05.020 · Cited by 9
Issy, A. C., Nascimento, G. C., de Abreu, G. H. D., Tristão, F. S. M., Bel, E. A. D., Duarte, T. T., & Bortolanza, M. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.002 · Cited by 8
Jing, S., Wang, Z., Zhang, J., Li, X., & Huang, R. (2021) · Pharmacognosy Magazine · doi:10.4103/pm.pm_291_19 · Cited by 8
Zebrafish as a potential model for stroke: A comparative study with standardized models
Borges, H. D. M., Dagostin, C. S., Córneo, E. D. S., Dondossola, E. R., Bernardo, H. T., Pickler, K. D. P., Pereira, B. D. C., de Oliveira, M. A., Scussel, R., Michels, M., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121200 · Cited by 7
Chakraborty, C., Pal, S., Doss, C. G. P., Wen, Z., & Lin, C.-S. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9725-5 · Cited by 8
McLarnon, J. G. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666191106095038 · Cited by 8
Togawa, N., Ayaki, T., Yoshii, D., Maki, T., Sawamoto, N., & Takahashi, R. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.137829 · Cited by 7
Bourzam, A., Hamdi, Y., Bahdoudi, S., Duraisamy, K., Mehdi, M. E., Basille, M., Dlimi, O., Kharrat, M., Véjux, A., Lizard, G., et al. (2024) · Cells · doi:10.3390/cells13141188 · Cited by 7
O'Connor, J. L., Fountos, D. M., Firouzan, B., Azizi, F., Ghasemi, R., & Kashfi, K. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00710 · Cited by 8
Repurposing of Minocycline, a Tetracycline Antibiotic, for Neurodegenerative Disorders
Bhandari, R., Sood, P., Thakur, D., & Kuhad, A. (2023) · Springer eBooks · doi:10.1007/978-981-19-5399-6_27 · Cited by 7
Liang, L., Fulton, R. E., Bradshaw‐Pierce, E. L., Pearson-Smith, J. N., Day, B. J., & Patel, M. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000229 · Cited by 7
Rangasamy, S. B., Dutta, D., Mondal, S., Majumder, M., Dasarathi, S., Chandra, G., & Pahan, K. (2022) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2022-0005 · Cited by 7
Hwang, D., Kim, H. G., Jang, J., & Oh, M. S. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/976270 · Cited by 7
Kang, J. M., Jung, J., Kim, H., Lim, H., Jang, S., & Oh, S. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1275-5 · Cited by 7
Bulduk, E. B., Kurt, G., Barun, S., Aydemir, Ö., Kiziltas, M., Öktem, M., Turhan, T., & Atilla, P. (2018) · Turkish Neurosurgery · doi:10.5137/1019-5149.jtn.22744-18.1 · Cited by 7
Cellular distribution of interleukin-1α-immunoreactivity after MPTP intoxication in mice
Hébert, G. A., Mingam, R., Arsaut, J., Dantzer, R., & Demotes‐Mainard, J. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.019 · Cited by 7
Glial Cells in ALS: The Missing Link?
Raibon, E., Todd, L. M., & Möller, T. (2008) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2008.04.003 · Cited by 8
Zhao, F.-L., Hu, J.-H., & Zhu, X. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1372 · Cited by 7
The contribution of type-I IFN-mediated neuroinflammation to Parkinson's disease progression
Chen, S., Crack, P. J., & Taylor, J. M. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101017 · Cited by 6
Minocycline Mitigation of Tremor Syndrome and Defect of Cognitive and Balance Induced by Harmaline
Department of Physiology, P. R. C., Maneshian, M., Nasirinezhad, F., Department of Physiology, P. R. C., Mohammadi, F., Intracellular Recording Lab, N. R. C., Behzadi, M., Intracellular Recording Lab, N. R. C., Asadi-Shekaari, M., Intracellular Recording Lab, N. R. C., et al. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.12.2.1980.1 · Cited by 4
Metadata
- Authors
- Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S.
- Affiliations
- Pediatrics and Genetics (US)
- Children's Hospital of Philadelphia (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-03-01
- Volume
- 22
- Issue
- 5
- Pages
- 1763-1771
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6758858
- OpenAlex
- W2148726772
- Cited by
- 1,183
- References
- 44
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 13 · 2023: 15 · 2022: 27 · 2021: 41 · 2020: 27 · 2019: 40 · 2018: 47 · 2017: 42 · 2016: 43 · 2015: 43 · 2014: 68 · 2013: 69 · 2012: 63
- FWCI
- 45.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- Parkinson's Disease Foundation (NS38370)
- Muscular Dystrophy Association
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (5r29ns037345-05, NS38370)
- National Institute on Aging (R01-AG13966, R01AG013966)
- National Institute of Neurological Disorders and Stroke (P50-NS38370, R01 NS 38586, R01 NS 42269, R29 NS37345, R01NS042269, R01NS038586, P50NS038370)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, microglial activation, minocycline, MPTP-induced neurotoxicity, neuroprotection, nitrotyrosine, IL-1β, NADPH oxidase, inducible nitric oxide synthase, nigrostriatal dopaminergic neurons, neuroinflammation, iNOS-deficient mice
- MeSH terms
- Animals, Anti-Bacterial Agents, Astrocytes, Corpus Striatum, Disease Models, Animal, Dose-Response Relationship, Drug, Interleukin-1, Mice, Inbred C57BL, Minocycline, Neurons, Substantia Nigra, Tyrosine, Tyrosine 3-Monooxygenase, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Up-Regulation, Microglia, Mice, Knockout, Neuroprotective Agents, Nitric Oxide Synthase, NADPH Oxidases, Parkinsonian Disorders, Mice, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
